Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V K Rustgi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver diseaseG Marino, V K Rustgi, G Salzberg, et al.
Hepatology (Baltimore, Md.)|February 1, 1990
Therapy of chronic hepatitis B with recombinant human alpha and gamma interferonA M Di Bisceglie, V K Rustgi, C Kassianides, et al.
Transplantation|May 8, 1999
Portopulmonary hypertension and the liver transplant candidateP C Kuo, J S Plotkin, S Gaine, et al.
Journal of Medical Virology|July 1, 1994
Spectrum of hepatitis E virus infection in IndiaM S Khuroo, V K Rustgi, G J Dawson, et al.
Annals of Internal Medicine|December 1, 1984
Hepatitis B virus infection in the acquired immunodeficiency syndromeV K Rustgi, J H Hoofnagle, J L Gerin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 12, 2001
Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative liversC E Marroquin, G Marino, P C Kuo, et al.
Hepatology (Baltimore, Md.)|May 5, 2000
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantationA S Gaweco, R H Wiesner, M Porayko, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2015
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirR K Sterling, A Kuo, V K Rustgi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver diseaseG Marino, V K Rustgi, G Salzberg, et al.
Hepatology (Baltimore, Md.)|February 1, 1990
Therapy of chronic hepatitis B with recombinant human alpha and gamma interferonA M Di Bisceglie, V K Rustgi, C Kassianides, et al.
Transplantation|May 8, 1999
Portopulmonary hypertension and the liver transplant candidateP C Kuo, J S Plotkin, S Gaine, et al.
Journal of Medical Virology|July 1, 1994
Spectrum of hepatitis E virus infection in IndiaM S Khuroo, V K Rustgi, G J Dawson, et al.
Annals of Internal Medicine|December 1, 1984
Hepatitis B virus infection in the acquired immunodeficiency syndromeV K Rustgi, J H Hoofnagle, J L Gerin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 12, 2001
Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative liversC E Marroquin, G Marino, P C Kuo, et al.
Hepatology (Baltimore, Md.)|May 5, 2000
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantationA S Gaweco, R H Wiesner, M Porayko, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2015
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirR K Sterling, A Kuo, V K Rustgi, et al.
Pageof 3